Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Okombo

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
ACS Infectious Diseases|July 17, 2019
Semisynthetic Antimycobacterial C-3 Silicate and C-3/C-21 Ester Derivatives of Fusidic Acid: Pharmacological Evaluation and Stability Studies in Liver Microsomes, Rat Plasma, and <i>Mycobacterium tuberculosis</i> cultureMathew Njoroge, Gurminder Kaur, Marlene Espinoza-Moraga, et al.
Plos Pathogens|October 28, 2022
Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stagesJohn Okombo, Sachel Mok, Tarrick Qahash, et al.
ACS Infectious Diseases|April 26, 2017
Antischistosomal Activity of Pyrido[1,2-a]benzimidazole Derivatives and Correlation with Inhibition of β-Hematin FormationJohn Okombo, Kawaljit Singh, Godfrey Mayoka, et al.
Nature Communications|September 24, 2020
Genetic screens reveal a central role for heme metabolism in artemisinin susceptibilityClare R Harding, Saima M Sidik, Boryana Petrova, et al.
Dalton Transactions (Cambridge, England : 2003)|August 4, 2016
Mono- and multimeric ferrocene congeners of quinoline-based polyamines as potential antiparasiticsTameryn Stringer, Carmen De Kock, Hajira Guzgay, et al.
Journal of Medicinal Chemistry|March 5, 2021
3-Hydroxy-propanamidines, a New Class of Orally Active Antimalarials Targeting Plasmodium falciparumTanja C Knaab, Jana Held, Bjoern B Burckhardt, et al.
Mbio|May 11, 2017
A Variant PfCRT Isoform Can Contribute to <i>Plasmodium falciparum</i> Resistance to the First-Line Partner Drug PiperaquineSatish K Dhingra, Devasha Redhi, Jill M Combrinck, et al.
Scientific Reports|November 26, 2013
Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in KenyaSteffen Borrmann, Judith Straimer, Leah Mwai, et al.
Journal of Medicinal Chemistry|December 19, 2018
Structure-Activity Relationship Studies and Plasmodium Life Cycle Profiling Identifies Pan-Active N-Aryl-3-trifluoromethyl Pyrido[1,2- a]benzimidazoles Which Are Efficacious in an in Vivo Mouse Model of MalariaGodfrey Mayoka, Mathew Njoroge, John Okombo, et al.
Mbio|December 7, 2023
Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered <i>Plasmodium falciparum</i> physiologyLaura M Hagenah, Satish K Dhingra, Jennifer L Small-Saunders, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
ACS Infectious Diseases|July 17, 2019
Semisynthetic Antimycobacterial C-3 Silicate and C-3/C-21 Ester Derivatives of Fusidic Acid: Pharmacological Evaluation and Stability Studies in Liver Microsomes, Rat Plasma, and <i>Mycobacterium tuberculosis</i> cultureMathew Njoroge, Gurminder Kaur, Marlene Espinoza-Moraga, et al.
Plos Pathogens|October 28, 2022
Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stagesJohn Okombo, Sachel Mok, Tarrick Qahash, et al.
ACS Infectious Diseases|April 26, 2017
Antischistosomal Activity of Pyrido[1,2-a]benzimidazole Derivatives and Correlation with Inhibition of β-Hematin FormationJohn Okombo, Kawaljit Singh, Godfrey Mayoka, et al.
Nature Communications|September 24, 2020
Genetic screens reveal a central role for heme metabolism in artemisinin susceptibilityClare R Harding, Saima M Sidik, Boryana Petrova, et al.
Dalton Transactions (Cambridge, England : 2003)|August 4, 2016
Mono- and multimeric ferrocene congeners of quinoline-based polyamines as potential antiparasiticsTameryn Stringer, Carmen De Kock, Hajira Guzgay, et al.
Journal of Medicinal Chemistry|March 5, 2021
3-Hydroxy-propanamidines, a New Class of Orally Active Antimalarials Targeting Plasmodium falciparumTanja C Knaab, Jana Held, Bjoern B Burckhardt, et al.
Mbio|May 11, 2017
A Variant PfCRT Isoform Can Contribute to <i>Plasmodium falciparum</i> Resistance to the First-Line Partner Drug PiperaquineSatish K Dhingra, Devasha Redhi, Jill M Combrinck, et al.
Scientific Reports|November 26, 2013
Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in KenyaSteffen Borrmann, Judith Straimer, Leah Mwai, et al.
Journal of Medicinal Chemistry|December 19, 2018
Structure-Activity Relationship Studies and Plasmodium Life Cycle Profiling Identifies Pan-Active N-Aryl-3-trifluoromethyl Pyrido[1,2- a]benzimidazoles Which Are Efficacious in an in Vivo Mouse Model of MalariaGodfrey Mayoka, Mathew Njoroge, John Okombo, et al.
Mbio|December 7, 2023
Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered <i>Plasmodium falciparum</i> physiologyLaura M Hagenah, Satish K Dhingra, Jennifer L Small-Saunders, et al.
Pageof 7